Rethinking Clinical Trials Grand Rounds: ACTIV-6 - A Direct-to-Participant Platform Trial of Repurposed Drugs for COVID-19

ACTIV-6: A Direct-to-Participant Platform Trial of Repurposed Drugs for COVID-19 in Non-hospitalized Patients

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features Susanna Naggie, MD, MHS, of Duke Clinical Research Institute and Elizabeth Shenkman, PhD, of the University of Florida.

Presenters
Susanna Naggie, MD, MHS
Associate Professor of Medicine
Duke Clinical Research Institute

Elizabeth Shenkman, PhD
Chair, Department of Health Outcomes and Biomedical Informatics
Co-Director, Clinical and Translational Science Institute (CTSI)
University of Florida

Learn More